Updated efficacy of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in patients with advanced renal cell carcinoma (aRCC) in the CLEAR study Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Porta, Camillo G.; Eto, Masatoshi; Motzer, Robert J.; De Giorgi, Ugo; Buchler, Tomas; Basappa, Naveen S.; Mendez Vidal, Maria Jose; Tjulandin, Sergei; Park, Se Hoon; Melichar, Bohuslav; Hutson, Thomas; Alemany, Carlos; McGregor, Bradley; He, Cixin Steven; Perini, Rodolfo; Mody, Kalgi; McKenzie, Jodi; Ebaid, Basant; Choueiri, Toni

authors

Publication Date

  • November 1, 2022

webpage

published in

category

start page

  • 122

end page

  • 123

volume

  • 18